u/Rich-Kaleidoscope-12

Hey everyone, wanted to drop some quick Due Diligence on CXApp Inc. ($CXAI). This stock is currently sitting at its absolute 52-week bottom around $0.14, completely flying under the retail radar despite putting up an incredible Q1 earnings report last week.

If you are looking for an actual tech/AI company with real revenue, a clean balance sheet, and a tiny market cap, look at the actual numbers:

1. The Q1 Earnings Beat (May 13, 2026)
   CXAI didn't just meet expectations; they beat them. They reported an EPS of -$0.09 (beating Wall Street estimates of -$0.11) and a revenue beat.

2. Insane High-Quality Revenue Mix
   This isn’t a hype-trap biotech company with zero products. CXAI has an 83% GAAP gross margin, and an incredible 98% of their revenue is software subscriptions (recurring SaaS revenue). Once an enterprise onboard, they don't leave.

3. Massive Commercial Momentum
   During the earnings call, management confirmed they secured over $5 Million in Total Contract Value from three new major enterprise organizations. These are multi-year agreements spanning operations across 100 countries. Furthermore, they were recently named a "Visionary" in the April 2026 Gartner Magic Quadrant for Workplace Experience Applications.

4. Deep Balance Sheet ($12.3M in Cash)
   A major risk with stocks under $0.50 is immediate bankruptcy or toxic dilution. CXAI actually increased their cash position to $12.3 million this quarter (up from $11.1 million last quarter). They have plenty of runway to scale operations.

5. The Upcoming June Catalyst (CXAI 2.0)
   The stock is currently compressed because they are transitioning from a legacy SaaS model to an AI-native licensing model (which temporarily delays revenue recognition patterns). In June, they are officially rolling out their "CXAI 2.0" Agentic AI platform. This is a purpose-built intelligent operating layer for enterprise workplaces, capitalizing on a $100B+ addressable market.

The Bottom Line:
At $0.15 the market capitalization is under $10 million, while their trailing twelve-month revenue is over $4.5 million and they have $12M+ in cold hard cash. Wall Street's current average consensus price target sits at $1.02.

There is a Nasdaq compliance timeline to monitor regarding a potential future reverse split to get back over $1.00, but fundamentally, the disconnect between a 14-cent share price and $5M in fresh multi-year enterprise contracts makes this a massive asymmetry play ahead of their June AI platform rollout.

What are your thoughts on this setup? I feel like it is a solid 30-60 day grab… unless they do a reverse split but I think they’re waiting on their roll out before making that choice.

Disclaimer: Not financial advice. Do your own research.

Hey everyone, wanted to drop some quick Due Diligence on CXApp Inc. ($CXAI). This stock is currently sitting at its absolute 52-week bottom around $0.14, completely flying under the retail radar despite putting up an incredible Q1 earnings report last week.

If you are looking for an actual tech/AI company with real revenue, a clean balance sheet, and a tiny market cap, look at the actual numbers:

1. The Q1 Earnings Beat (May 13, 2026)
   CXAI didn't just meet expectations; they beat them. They reported an EPS of -$0.09 (beating Wall Street estimates of -$0.11) and a revenue beat.

2. Insane High-Quality Revenue Mix
   This isn’t a hype-trap biotech company with zero products. CXAI has an 83% GAAP gross margin, and an incredible 98% of their revenue is software subscriptions (recurring SaaS revenue). Once an enterprise onboard, they don't leave.

3. Massive Commercial Momentum
   During the earnings call, management confirmed they secured over $5 Million in Total Contract Value from three new major enterprise organizations. These are multi-year agreements spanning operations across 100 countries. Furthermore, they were recently named a "Visionary" in the April 2026 Gartner Magic Quadrant for Workplace Experience Applications.

4. Deep Balance Sheet ($12.3M in Cash)
   A major risk with stocks under $0.50 is immediate bankruptcy or toxic dilution. CXAI actually increased their cash position to $12.3 million this quarter (up from $11.1 million last quarter). They have plenty of runway to scale operations.

5. The Upcoming June Catalyst (CXAI 2.0)
   The stock is currently compressed because they are transitioning from a legacy SaaS model to an AI-native licensing model (which temporarily delays revenue recognition patterns). In June, they are officially rolling out their "CXAI 2.0" Agentic AI platform. This is a purpose-built intelligent operating layer for enterprise workplaces, capitalizing on a $100B+ addressable market.

The Bottom Line:
At $0.14, the market capitalization is under $10 million, while their trailing twelve-month revenue is over $4.5 million and they have $12M+ in cold hard cash. Wall Street's current average consensus price target sits at $1.02.

There is a Nasdaq compliance timeline to monitor regarding a potential future reverse split to get back over $1.00, but fundamentally, the disconnect between a 14-cent share price and $5M in fresh multi-year enterprise contracts makes this a massive asymmetry play ahead of their June AI platform rollout.

What are your thoughts on this setup?

Disclaimer: Not financial advice. Do your own research.